Yervoi 50mg Injection: Effective Treatment for Your Needs

Active component: Ipilimumab

Uses:

• Advanced melanoma (type of skin cancer);
• Advanced kidney cancer;
• Liver cancer;
• Colorectal cancer;
• Non-small cell lung cancer (type of lung cancer).

Therapeutic effects:

• Helps the body's immune system to attack cancer cells;
• Blocks a protein called CTLA-4, allowing T cells to become more active and better able to recognize and destroy cancer cells.

Administration:

• Administered by a healthcare professional through an intravenous (IV) infusion;
• The medication is prepared as a solution and given for about 90 minutes;
• Dose depends on factors such as the patient's weight and overall health and the specific cancer being treated;
• Treatment is typically given in cycles, with each cycle consisting of several infusions given over weeks or months.

Safety advice:

• Not safe for use during pregnancy;
• Consult a healthcare provider if you are a breastfeeding mother before taking this medication;
• Avoid alcohol consumption;
• Avoid driving or operating machinery if you experience side effects such as fatigue, dizziness, or blurred vision;
• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.

Side effects:

• Serious: inflammation of the colon (colitis), inflammation of the liver (hepatitis), inflammation of the lungs (pneumonitis), inflammation of the pituitary gland (hypophysitis), inflammation of the skin (dermatitis), nerve damage (neuropathy), hypothyroidism, adrenal insufficiency, diabetes;
• Common: fatigue, diarrhea, itching, rash, nausea, loss of appetite, headache, insomnia, muscle pain, joint pain.

FAQ:

• Q1. Can I receive vaccinations while on Yervoi 50mg Injection treatment? — It is generally recommended to avoid live vaccines during Yervoi 50mg Injection treatment.
• Q2. Can I donate blood while on Yervoi 50mg Injection treatment? — There is no data on the safety of donating blood while on Yervoi 50mg Injection treatment, and it is generally recommended to avoid blood donation during treatment and for at least 5 months after the last dose.
• Q3. Can I develop autoimmune disorders while on Yervoi 50mg Injection treatment? — Yervoi 50mg Injection can cause immune-mediated adverse reactions, including autoimmune disorders.
• Q4. Can Yervoi 50mg Injection be used in combination with other cancer treatments? — Yervoi 50mg Injection can be combined with other cancer treatments, but the combination may increase the risk of adverse reactions and should only be used under the supervision of a healthcare provider.
• Q5. How long does the effect of Yervoi 50mg Injection last? — The effects of Yervoi 50mg Injection on the immune system can last for several weeks to months after the last dose.

Fact box:

• Molecule name: Ipilimumab;
• Therapeutic class: Anticancer;
• Pharmacological class: Monoclonal antibody immunotherapy.

Tags: medical-injection, yervoi, drug, 50mg, pharmaceutical, medicine, anti-inflammatory